Could Google's Pill Detect Diseases Before They Become Chronic?

the MPR take:

Google’s research laboratory, known as Google X, is currently working to develop a pill to identify cancers, heart diseases, and other chronic and fatal conditions. Known as the “Nanoparticle Platform,” the company is designing an ingestible nanoparticle with magnetic material and antibodies or proteins that, when released into the bloodstream, could pinpoint molecules that may signify specific health conditions. A wearable device could then be used to gather the magnetic material back together, complete with information on the molecules detected. This data could then be read by the device and sent to the patient and their physician for consistent health monitoring. Andrew Conrad, head of life and sciences at Google X, states that these nanoparticules are already used in some medicines and contrast agents and are safe. So far it is unknown where Google X is in the development state or when the technology may be ready, but the prospect of disease detection without complicated and invasive diagnostics is very appealing to patients and clinicians alike.

Google is attempting to develop a pill that would send microscopic particles into the bloodstream in an effort to identify cancers, imminent heart attacks, and other diseases.